René Lafont Selected Research

Respiratory Insufficiency (Respiratory Failure)

2/2024	Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial.
12/2021	A comparison between virus- versus patients-centred therapeutic attempts to reduce COVID-19 mortality.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

René Lafont Research Topics

Disease

6	Macular Degeneration (Age-Related Maculopathy) 03/2024 - 01/2016
4	Inflammation (Inflammations) 03/2024 - 02/2012
3	Phototoxic Dermatitis (Phototoxicity) 03/2024 - 01/2016
3	COVID-19 02/2024 - 01/2021
2	Respiratory Insufficiency (Respiratory Failure) 02/2024 - 12/2021
2	Vision Disorders (Hemeralopia) 01/2020 - 01/2016
2	Obesity 04/2014 - 02/2012
1	Retinal Degeneration 03/2023
1	Sarcopenia 01/2023
1	Pneumonia (Pneumonitis) 01/2021
1	Stargardt Disease 01/2020
1	Eye Diseases (Eye Disease) 01/2020
1	Insulin Resistance 02/2012
1	Dehydration (Water Stress) 01/2002

Drug/Important Bio-Agent (IBA)

6	norbixinIBA 03/2024 - 01/2016
5	A2-E (N-retinylidene-N-retinylethanolamine)IBA 03/2024 - 01/2016
5	Ecdysterone (20 Hydroxyecdysone)IBA 02/2024 - 02/2012
3	Retinaldehyde (Retinal)IBA 03/2024 - 01/2016
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2024 - 01/2021
2	LipidsIBA 01/2019 - 04/2014
1	Retinoid X Receptors (Retinoid X Receptor)IBA 03/2024
1	Interleukin-6 (Interleukin 6)IBA 03/2024
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2024
1	Oxygen (Dioxygen)IBA 02/2024
1	AmidesIBA 03/2023
1	Phytosterols (Plant Sterols)IBA 01/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2021
1	Antiviral Agents (Antivirals)IBA 12/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	diazepinylbenzoic acidIBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021
1	ZeaxanthinsIBA 01/2020
1	AntioxidantsIBA 01/2020
1	Carotenoids (Carotene)IBA 01/2020
1	LipofuscinIBA 01/2020
1	LuteinIBA 01/2020
1	Leukotriene A4IBA 01/2019
1	Leukotriene B4IBA 01/2019
1	leukotriene A4 hydrolaseIBA 01/2019
1	AminopeptidasesIBA 01/2019
1	Retinal Pigments (Pigments, Visual)IBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 04/2014
1	Messenger RNA (mRNA)IBA 02/2012
1	Plasminogen Activator Inhibitor 1IBA 02/2012
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 02/2012
1	OsteopontinIBA 02/2012
1	AdipokinesIBA 02/2012
1	EcdysteroidsIBA 01/2002
1	turkesteroneIBA 01/2002
1	muristerone AIBA 01/2002
1	ajugasterone CIBA 01/2002

Therapy/Procedure

1	Artificial Respiration (Mechanical Ventilation) 02/2024